Do you want to skip to content? Skip to content
Argentina Argentina Belize Belize Brasil Brasil Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Costa Rica Costa Rica Curaçao Curaçao El Salvador El Salvador Ecuador Ecuador Guatemala Guatemala Guyana Guyana Honduras Honduras Jamaica Jamaica México México Nicaragua Nicaragua Panamá Panamá Perú Perú Puerto Rico Puerto Rico República Dominicana República Dominicana Suriname Suriname Venezuela Venezuela United States (English) United States (English) België België Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Deutschland Deutschland Eesti Eesti España España France France Hrvatska Hrvatska Ireland Ireland Ísland Ísland Italia Italia Latvija Latvija Lietuva Lietuva Magyarország Magyarország Malta Malta Nederland Nederland Norge Norge Polska Polska Portugal Portugal România România Schweiz (Deutsch) Schweiz (Deutsch) Suisse (Français) Suisse (Français) Slovenija Slovenija Slovensko Slovensko Srbija Srbija Suomi Suomi Sverige Sverige Türkiye Türkiye United Kingdom United Kingdom Österreich Österreich Ελλάδα Ελλάδα България България Македонија Македонија Россия Россия Україна Україна South-Africa South-Africa ישראל ישראל الأردن الأردن الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين المملكة العربية السعودية المملكة العربية السعودية ایران ایران پاکستان پاکستان عُمان عُمان قطر قطر لبنان لبنان مصر مصر العراق العراق الكويت الكويت Australia Australia Hong Kong SAR Hong Kong SAR 中国香港 中国香港 India India Indonesia Indonesia Malaysia Malaysia New Zealand New Zealand Philippines Philippines Singapore Singapore Việt Nam Việt Nam ไทย ไทย 대한민국 대한민국 中国 中国 中国台湾 中国台湾 日本 日本
Argentina Argentina Belize Belize Brasil Brasil Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Costa Rica Costa Rica Curaçao Curaçao El Salvador El Salvador Ecuador Ecuador Guatemala Guatemala Guyana Guyana Honduras Honduras Jamaica Jamaica México México Nicaragua Nicaragua Panamá Panamá Perú Perú Puerto Rico Puerto Rico República Dominicana República Dominicana Suriname Suriname Venezuela Venezuela United States (English) United States (English) België België Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Deutschland Deutschland Eesti Eesti España España France France Hrvatska Hrvatska Ireland Ireland Ísland Ísland Italia Italia Latvija Latvija Lietuva Lietuva Magyarország Magyarország Malta Malta Nederland Nederland Norge Norge Polska Polska Portugal Portugal România România Schweiz (Deutsch) Schweiz (Deutsch) Suisse (Français) Suisse (Français) Slovenija Slovenija Slovensko Slovensko Srbija Srbija Suomi Suomi Sverige Sverige Türkiye Türkiye United Kingdom United Kingdom Österreich Österreich Ελλάδα Ελλάδα България България Македонија Македонија Россия Россия Україна Україна South-Africa South-Africa ישראל ישראל الأردن الأردن الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين المملكة العربية السعودية المملكة العربية السعودية ایران ایران پاکستان پاکستان عُمان عُمان قطر قطر لبنان لبنان مصر مصر العراق العراق الكويت الكويت Australia Australia Hong Kong SAR Hong Kong SAR 中国香港 中国香港 India India Indonesia Indonesia Malaysia Malaysia New Zealand New Zealand Philippines Philippines Singapore Singapore Việt Nam Việt Nam ไทย ไทย 대한민국 대한민국 中国 中国 中国台湾 中国台湾 日本 日本

Stigma, not condition, is the biggest barrier for 1 in 3 people living with chronic conditions, according to new Convatec research

London, UK and Boston, US, 27 October 2025 – Convatec, a leading medical products and technologies company focused on solutions for the management of chronic conditions, today announced the publication of a new report revealing that millions of people feel they need to hide their health conditions in plain sight. Perspectives on living with chronic conditions – research undertaken in the United States, United Kingdom, Germany, Italy, and Brazil – shows that while one in three people[1] surveyed lives with a chronic physical condition, nearly 60% routinely downplay their symptoms to avoid making other people feel uncomfortable.

Key findings

  • Chronic conditions are widespread yet remain invisible: 1 in 3 people live with a chronic physical condition, yet most (84%) of these conditions are not visible to others
  • Awareness is uneven: While 91% of the public are familiar with cancer, only 49% know “at least a little” about ostomy or continence conditions, despite their widespread impact
  • Masking is common: 59% of people with chronic conditions downplay their health issues to avoid making other people feel uncomfortable
  • Self-advocacy is crucial: 43% of people with chronic conditions report needing to advocate for themselves in healthcare settings because their condition is misunderstood or minimised

The comprehensive study, conducted across five countries with large, diverse populations, surveyed over 10,000 adults including 3,400 individuals living with chronic conditions such as heart disease, diabetes, multiple sclerosis, Crohn's disease, and incontinence - conditions that collectively account for six of the ten leading causes of death globally.

The findings reveal widespread social stigma tied to chronic conditions, which has significant implications for employers, healthcare professionals (HCPs) and policymakers. Convatec’s research shows that public misconceptions about chronic conditions may be driving workplace discrimination and inadequate support systems.

Misconceptions about lived experiences are pervasive

The research uncovers a culture of masking symptoms, where people with chronic conditions routinely downplay the challenges of managing their condition to avoid making other people feel uncomfortable. Affecting 59% of those surveyed, this phenomenon is both widespread and deeply damaging, contributing to isolation, misunderstanding, and inadequate support in workplaces, healthcare settings, and communities more broadly.

The research reveals that public perceptions consistently misrepresent the lived experience of chronic conditions. While 82% of the public believe chronic conditions severely limit a person's ability to work, only 41% of those affected say their health has limited their employment opportunities. Similarly, 67% of the public think chronic conditions damage relationships, yet just 34% of people living with chronic conditions report this as their experience. Society tends to overestimate limitations while underestimating both the prevalence and the resilience of those affected. 

Emotional impact is often overlooked

Perhaps most concerning is the emotional toll living with a chronic condition takes. More than half of survey respondents felt depressed or overwhelmed at diagnosis, and 40% continue to feel misunderstood even after adapting to their condition. The challenge extends far beyond medical management: 70% say the average person does not understand what it is like to live with a chronic condition, while 43% report having to advocate for themselves in healthcare settings because their condition is misunderstood or overlooked.

Bruno Pinheiro, President & Chief Operating Officer, Ostomy Care at Convatec, said:

“Chronic conditions are a global reality, yet many keep their struggles hidden. Our findings show the urgent need for genuine understanding and practical support required. I’m proud that, through Convatec’s me+ programme – now entering its tenth year, Convatec is committed to providing free, comprehensive resources, dedicated nurse support, and a supportive community for people living with stoma or continence conditions - empowering individuals to live with greater confidence and dignity.” 

Jeanine Gleba, Advocacy Manager, United Ostomy Associations of America (UOAA), said:

“As a leading organisation advocating for people living with an ostomy or continent diversion, United Ostomy Associations of America (UOAA) is proud to partner with Convatec and strongly supports amplifying the voices of people living with an ostomy. Convatec’s research validates the need to work together to raise awareness, challenge misconceptions, and change narrative. By sharing lived experiences, which has been a cornerstone of UOAA’s advocacy efforts since the beginning, we can help drive meaningful change for those living with an ostomy and their loved ones.” 

A spokesperson at Colostomy UK said: 

“Convatec’s report shines a light on the importance of awareness, understanding, and peer support for people living with a stoma. At Colostomy UK, we know how life-changing it can be to feel seen, supported, and connected. Signposting to not-for-profit organisation like ours is vital, we’re here every step of the way, helping people find reassurance, community, and confidence to live life to the fullest.”

Calling for greater understanding and support

Perspectives on living with chronic conditions is a powerful call to action for healthcare leaders, policy makers and employees to acknowledge the widespread but often overlooked impact of chronic conditions. With 74% of affected people hoping for greater public awareness, Convatec urges action to address stigma in both workplace and healthcare settings, and to invest in education and support systems that reflect the real needs of those affected.

As part of its commitment to improving the quality of life for people living with stomas and continence needs, Convatec offers support through its global me+ programme which is designed to empower, educate, and connect people. Convatec invites partners to leverage me+ as a resource in their own efforts to build organisations where everyone can thrive while managing chronic health challenges.

- ENDS -

About the research

Convatec commissioned a nationally representative survey of 10,025 adults across the US, UK, Brazil, Italy, and Germany, including 3,400 individuals living with a chronic condition, from 11-19 August 2025. The study explored the realities and perceptions of living with a physical chronic condition, including musculoskeletal, metabolic, cardiovascular, respiratory, neurological, autoimmune, cancer, wound care, ostomy/continence, rare/genetic, and palliative/supportive care needs. Collectively, these conditions account for six of the ten leading causes of death  globally.

 

Perspectives on living with chronic conditions is available for  download here.

 

Contact

MediaRelations@convatec.com 


Notes to editors:

  • High-resolution images and interview opportunities available upon request
  • Regional data breakdowns available in appendix
  • Patient case studies available (with consent)

About Convatec me+ programme

Launched in the United States and United Kingdom in 2015 and scaled globally in other markets over the past decade, the me+ programme supports people managing chronic conditions to help them enjoy their lives as well as support for clinicians and caregivers. The programme provides access to product samples, a dedicated team of nurses over the phone and a range of online resources covering lifestyle tips and advice, educational tools and peer-to-peer support related to continence care and ostomy care. 

About Convatec

Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. With more than 10,000 colleagues, we provide products and services in around 90 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention, treatment for hard to heal wounds, at-risk skin and ulcerated tissue to supporting debilitating conditions, improved patient outcomes and reduced care costs. Convatec's revenues in 2024 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more please visit http://www.convatecgroup.com 

 

 

Appendix: Regional data breakdown

 

United States

  • Chronic condition prevalence & impact: 41% of US adults report living with a physical chronic health condition, and 50% say a close friend or relative is affected.
  • Work & financial strain: Half (50%) of Americans with chronic conditions say their health has affected their ability to work, and 50% have experienced financial difficulties due to their condition.
  • Emotional toll: 58% felt “depressed and overwhelmed” at diagnosis, and 41% still feel socially isolated because of their condition.
  • Awareness: 63% of Americans without chronic conditions want to learn more about the daily experiences of those that do.

 

United Kingdom

  • Chronic condition prevalence & impact: 28% of UK adults report living with a physical chronic health condition, and nearly half (48%) of those without a diagnosis have a close friend or relative who does.
  • Work & financial strain: Nearly half (48%) of people with chronic conditions in the UK say their health has affected their ability to work, and 38% have experienced financial difficulties as a result.
  • Emotional toll: 58% felt “depressed and overwhelmed” at diagnosis, and 41% still feel socially isolated because of their condition.
  • Awareness: 77% of UK adults support greater public awareness and education.


[1] Convatec first identified the ‘1 in 3’ prevalence of hidden and chronic conditions in its 2022 Hidden Illnesses study, and has continued to track and validate this finding in subsequent global research, including recent research across 13 countries for its Care Gap Series.

Press Release

See all

27-Oct-25

Corporate

logo, company name

Convatec announces Karim Bitar has passed away

Interim leadership arrangements remain in place and a further announcement will be made in due course

Read more Read more

27-Oct-25

Corporate

Ostomy Care

Stigma, not condition, is the biggest barrier for 1 in 3 people living with chronic conditions

Stigma, not condition, is the biggest barrier for 1 in 3 people living with c...

New report reveals that millions of people feel they need to hide their health conditions

Read more Read more

08-Oct-25

Corporate

logo, company name

Convatec announces closing of $500 Million 5.300% Senior Notes due 2035

Read more Read more

02-Oct-25

Corporate

logo, company name

Convatec announces pricing of $500 Million 5.300% Senior Notes due 2035

Read more Read more

01-Oct-25

Corporate

a building with a lot of windows

Convatec announces plans to invest more than $1 billion in R&D facilities – ...

Major expansions in the US and UK

Read more Read more

29-Sep-25

Corporate

logo, company name

Convatec announces offering of Senior Notes

Read more Read more

22-Sep-25

Corporate

Advanced Wound Care

logo, company name

Convatec secures regulatory approval for ConvaMatrix™ in UK and Europe, suppo...

ConvaMatrix has significant potential for the management of hard to heal wounds such as venous leg ulcers and diabeti...

Read more Read more

02-Sep-25

Corporate

Advanced Wound Care

logo, company name

Convatec strengthens Leadership Team to support growth

Read more Read more

20-Aug-25

Corporate

logo, company name

Convatec commences share buyback programme

Non-discretionary share buyback programme to return up to $300 million of surplus capital to shareholders

Read more Read more

04-Aug-25

Corporate

logo, company name

Update regarding Chief Executive Officer

Read more Read more

29-Jul-25

Corporate

Financial Performance

logo, company name

Interim results for the six months ended 30 June 2025

Delivering broad-based revenue growth, margin expansion & double-digit EPS growth

Read more Read more

24-Jul-25

Corporate

Advanced Wound Care

text

Convatec secures US and European regulatory clearance for Aquacel™ ConvaFiber...

Read more Read more

15-Jul-25

Corporate

Advanced Wound Care

logo, company name

Convatec responds to CMS draft payment proposal for skin substitutes in the U...

Convatec notes the draft payment proposal from the Centers for Medicare & Medicaid Services

Read more Read more

01-Jul-25

Corporate

Continence Care

Ostomy Care

Convatec logo

Comment on CMS proposed rule change issued 30 June 2025

Convatec notes the Centers for Medicare & Medicaid Services (CMS) proposed rule published on 30 June 2025

Read more Read more

26-Jun-25

Corporate

Infusion Care

Neria Guard infusion set

Convatec welcomes regulatory approval of subcutaneous apomorphine infusion f...

Convatec’s Neria™ Guard infusion set is used for continuous subcutaneous infusion of a wide range of pharmaceuticals ...

Read more Read more

22-May-25

Corporate

Financial Performance

logo, company name

AGM trading update for the four months ended 30 April 2025

Strong start to the year, on track to deliver targets

Read more Read more